AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Recruitingn/aAges 18 Years - 80 YearsFemaleNorthwestern University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
DISEASE CHARACTERISTICS: * Meets one of the following criteria: * Considered to be at increased risk for developing ovarian cancer, as defined by one of the following: * Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer * Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor * A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer * Increased risk as deemed by a certified genetic counselor * Undergoing surgery for a gynecologic condition, including any of the following: * Diagnosis of a reproductive cancer * Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts) * Highly suspicious adnexal mass * Risk-reducing prophylactic oophorectomy PATIENT CHARACTERISTICS: Age * Between the ages of 18 and 80
๐Ÿ’Š

What it tests

  • Ca-125
  • screening questionnaire administration
  • Surgery
๐Ÿ“

Where

1 site
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy